Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.
Davenport AJ, Neagoe I, Bräuer N, Koch M, Rotgeri A, Nagel J, Laux-Biehlmann A, Machet F, Coelho AM, Boyce S, Carty N, Gemkow MJ, Hess SD, Zollner TM, Fischer OM.
Davenport AJ, et al.
Sci Rep. 2021 Oct 6;11(1):19877. doi: 10.1038/s41598-021-99177-0.
Sci Rep. 2021.
PMID: 34615939
Free PMC article.